[go: up one dir, main page]

IE890359L - Indolocarbazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing them - Google Patents

Indolocarbazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing them

Info

Publication number
IE890359L
IE890359L IE890359A IE35989A IE890359L IE 890359 L IE890359 L IE 890359L IE 890359 A IE890359 A IE 890359A IE 35989 A IE35989 A IE 35989A IE 890359 L IE890359 L IE 890359L
Authority
IE
Ireland
Prior art keywords
atoms
group
radical
denote
hydrogen
Prior art date
Application number
IE890359A
Other versions
IE65256B1 (en
Inventor
Jurgen Kleinschroth
Johannes Hartenstein
Hubert Barth
Christoph Schachtele
Claus Rudolph
Gunter Weinheimer
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of IE890359L publication Critical patent/IE890359L/en
Publication of IE65256B1 publication Critical patent/IE65256B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Novel indolocarbazole derivatives of the general formula I <IMAGE> in which R<1> and R<2> are identical or different and denote hydrogen, a straight-chain or branched alkyl group having 1 to 6 C atoms, a benzyl group, an unsubstituted or substituted aminoalkyl group having up to 12 C atoms, an alkoxycarbonylalkyl radical having up to 6 C atoms, a radical -CH2-CO-NR<3>R<4> in which R<3> and R<4> are identical or different and represent hydrogen, an alkyl group having 1 to 4 C atoms or a benzyl group, or R<1> and/or R<2> denote a haloalkyl, hydroxyalkyl or alkoxyalkyl radical each having up to 6 C atoms, a benzoyloxyalkoxyalkyl, acetyloxyalkoxyalkyl or hydroxyalkoxyalkyl radical each having up to 11 C atoms, or an acyl group having 1 to 4 C atoms or R<1> and R<2> together denote an alkylene group having 2 to 4 C atoms, optionally substituted by hydroxyl, C1-4-alkoxy or amino, X and Y are either identical and in each case both denote hydrogen, or X and Y are different, one of the radicals X or Y representing hydrogen and the other of the two radicals denoting a hydroxyl or an alkoxy group having up to 4 C atoms, with the proviso that not all radicals R<1>, R<2>, X and Y simultaneously denote hydrogen, and their pharmacologically acceptable salts, process for the preparation of the compounds I or of regioisomer mixtures of two of these compounds I and medicines containing at least one of the compounds I.
IE35989A 1988-02-06 1989-02-03 Indolocarbazole derivatives processes for the preparation thereof and pharmaceutical compositions containing them IE65256B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3803620A DE3803620A1 (en) 1988-02-06 1988-02-06 INDOLOCARBAZOL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THE SAME

Publications (2)

Publication Number Publication Date
IE890359L true IE890359L (en) 1989-08-06
IE65256B1 IE65256B1 (en) 1995-10-18

Family

ID=6346797

Family Applications (1)

Application Number Title Priority Date Filing Date
IE35989A IE65256B1 (en) 1988-02-06 1989-02-03 Indolocarbazole derivatives processes for the preparation thereof and pharmaceutical compositions containing them

Country Status (16)

Country Link
EP (1) EP0328000B1 (en)
JP (1) JP2866096B2 (en)
KR (1) KR890013035A (en)
CN (1) CN1035667A (en)
AT (1) ATE117304T1 (en)
AU (1) AU616468B2 (en)
CA (1) CA1337767C (en)
DD (1) DD283394A5 (en)
DE (2) DE3803620A1 (en)
DK (1) DK51489A (en)
ES (1) ES2066798T3 (en)
GR (1) GR3015194T3 (en)
HU (1) HU203758B (en)
IE (1) IE65256B1 (en)
PT (1) PT89623B (en)
ZA (1) ZA89861B (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3010675B2 (en) * 1989-03-23 2000-02-21 萬有製薬株式会社 Antitumor substance BE-13793C
WO1991009034A1 (en) * 1989-12-14 1991-06-27 Schering Corporation Indolocarbazoles from saccharothrix aerocolonigenes subsp. copiosa subsp. nov. scc 1951 atcc 53856
US5618809A (en) * 1989-12-14 1997-04-08 Schering Corporation Indolocarbazoles from saccharothrix aerocolonigenes copiosa subsp. nov SCC 1951 ATCC 53856
DE3942296A1 (en) * 1989-12-21 1991-06-27 Goedecke Ag INDOLOCARBAZOL DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF
US5668271A (en) * 1991-11-29 1997-09-16 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazole derivatives
US5591842A (en) * 1991-11-29 1997-01-07 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazole derivatives
AU685389B2 (en) * 1992-03-20 1998-01-22 Wellcome Foundation Limited, The Further indole derivatives with antiviral activity
DE4243321A1 (en) * 1992-12-21 1994-06-23 Goedecke Ag Amino acid derivatives of heterocycles as PKC inhibitors
US5721230A (en) * 1993-05-10 1998-02-24 Hoffmann-La Roche Inc. Substituted pyrroles
AU678435B2 (en) * 1993-05-10 1997-05-29 F. Hoffmann-La Roche Ag Substituted pyrroles
DK0699204T3 (en) * 1993-05-28 1999-02-22 Cephalon Inc Use of indolocarbazole derivatives for the treatment of a pathological condition in the prostate
US5468872A (en) * 1993-09-16 1995-11-21 Cephalon, Inc. K-252a functional derivatives potentiate neurotrophin-3 for the treatment of neurological disorders
US5541347A (en) * 1993-12-07 1996-07-30 Eli Lilly And Company Synthesis of bisindolylmaleimides
DK0657411T3 (en) * 1993-12-07 1999-11-15 Lilly Co Eli Improved synthesis of bisindolylmaleimides
US5723456A (en) * 1993-12-07 1998-03-03 Eli Lilly & Company Therapeutic treatment for cardiovascular diseases
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
UA44690C2 (en) * 1993-12-07 2002-03-15 Елі Ліллі Енд Компані Macrocyclic compounds imides BIS-indole-maleic acid, a way of its preparation and pharmaceutical compositions macrocyclic compounds imides BIS-indole-maleic acid and bis-indole-maleic anhydride, METHOD FOR PRODUCING (optional)
US5843935A (en) * 1993-12-07 1998-12-01 Eli Lilly And Company Protein kinase C inhibitors
AU1339895A (en) * 1993-12-23 1995-07-10 Eli Lilly And Company Protein kinase c inhibitors
US5922860A (en) * 1994-05-09 1999-07-13 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
US5804564A (en) * 1994-05-09 1998-09-08 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
US5481003A (en) * 1994-06-22 1996-01-02 Eli Lilly And Company Protein kinase C inhibitors
US5491242A (en) * 1994-06-22 1996-02-13 Eli Lilly And Company Protein kinase C inhibitors
US5616724A (en) * 1996-02-21 1997-04-01 Cephalon, Inc. Fused pyrrolo[2,3-c]carbazole-6-ones
CA2245029A1 (en) 1998-03-13 1999-09-13 University Of British Columbia Granulatimide compounds as g2 checkpoint inhibitors
WO1999047522A1 (en) * 1998-03-13 1999-09-23 The University Of British Columbia Granulatimide derivatives for use in cancer treatment
US6653290B2 (en) 2000-10-06 2003-11-25 Bristol-Myers Squibb Company Tumor proliferation inhibitors
US6855698B2 (en) 2001-03-22 2005-02-15 Bristol-Myers Squibb Company Topoisomerase I selective cytotoxic sugar derivatives of indolopyrrolocarbazoles
CA2393720C (en) 2002-07-12 2010-09-14 Eli Lilly And Company Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
CN117486782A (en) * 2023-12-29 2024-02-02 中国医学科学院药用植物研究所 N-substituted carbazole derivative and preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737496A (en) * 1986-10-01 1988-04-12 Ciba-Geigy Corporation 1,3,4,16b-tetrahydro-2H,10H-indolo[2,1-c]pyrazino-[1,2-a][1,4]benzodiazepines useful as serotonin-2 receptor antagonists

Also Published As

Publication number Publication date
ES2066798T3 (en) 1995-03-16
CN1035667A (en) 1989-09-20
EP0328000A2 (en) 1989-08-16
JPH02149520A (en) 1990-06-08
HU203758B (en) 1991-09-30
DE3803620A1 (en) 1989-08-17
PT89623B (en) 1994-02-28
IE65256B1 (en) 1995-10-18
DE58908892D1 (en) 1995-03-02
PT89623A (en) 1989-10-04
CA1337767C (en) 1995-12-19
GR3015194T3 (en) 1995-05-31
AU2960789A (en) 1989-08-10
DD283394A5 (en) 1990-10-10
AU616468B2 (en) 1991-10-31
JP2866096B2 (en) 1999-03-08
EP0328000B1 (en) 1995-01-18
ATE117304T1 (en) 1995-02-15
ZA89861B (en) 1989-11-29
DK51489A (en) 1989-08-07
KR890013035A (en) 1989-09-21
DK51489D0 (en) 1989-02-03
EP0328000A3 (en) 1991-04-03

Similar Documents

Publication Publication Date Title
ZA89861B (en) Indolocarbazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
GB8919417D0 (en) Novel compounds
GB8919434D0 (en) Novel compounds
HUT62602A (en) Process for producing pharmaceutically active hydrazine derivatives
AR033996A1 (en) A 7-OXO-PYRIDOPIRIMIDINE, ITS USE, A PROCESS TO PREPARE IT, A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, A PROCESS TO PRODUCE A PYRIMIDINE, A PROCESS TO PRODUCE A PYRIDOPIRIMIDINE, AND PREPARED COMPOUNDS THROUGH
IL77452A0 (en) Derivatives of arylcyclobutylalkylamines,their preparation and pharmaceutical compositions containing them
DE3661913D1 (en) Derivatives of 2,3-dihydro-benzofurane, processes for their preparation and pharmaceutical compositions containing them
DK96783A (en) PROCEDURE FOR PREPARING 4 &#39;&#39; - EPIERYTHROMYCIN A OR DERIVATIVES THEREOF
DE3065435D1 (en) Thiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
HUT50142A (en) Process for producing allyl-mercapto-acetyl-sidnonimine derivatives and pharmaceutical compositions containing them
IL106356A (en) 4-amino-n-(4-methyl- 4-piperidinyl)- 2-methoxybenzamides, their preparation and pharmaceutical compositions containing them
ATE134376T1 (en) MONO- AND BIS-ALKYLAMINOANTHRACYCLINES
IE901314L (en) 2- substituted-n,n&#39;-di(trimethoxybenzoyl)piperazines
DE69029781D1 (en) Anthracycline glycoside derivatives and process for their preparation
ZA918991B (en) Imidazole compounds,process for the preparation thereof and pharmaceutical compositions containing them
DE3161553D1 (en) Thiazolo(3,2-a)pyrimidine derivatives, their preparation and pharmaceutical compositions containing them
FR2630111B1 (en) NOVEL TRIENIC DERIVATIVES WITH CHROMENIC STRUCTURE, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
SE9203824L (en) BENSOFURANYLIMIDAZOLE DERIVATIVES, PROCEDURES FOR PREPARING THEREOF AND THERAPEUTIC COMPOSITIONS CONTAINING THEM
ZA934110B (en) Diacylglycerol nicotinates, process fot their preparation and the pharmaceutical compositions which contain them
ES2023760A6 (en) Benzothiazine derivatives, their preparation and their uses as medicines or as intermediates for the synthesis of medicines.
HUT45059A (en) Process for producing abeoergoline derivatives
ATE36154T1 (en) 4-PHENYLAMINOPYRIDIN DERIVATIVES, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICALS CONTAINING THEM.
ES2006336A6 (en) 2,3-Dihydro-3-phenyl-benzofuran-2-one acetamide derivatives, processes for their preparation and pharmaceutical compositions containing them.
KR890009916A (en) Rapdan derivatives, methods for their preparation and use as medicaments thereof

Legal Events

Date Code Title Description
MM4A Patent lapsed